Is CTI BioPharma Corp. (CTIC) a Buy, Sell, or Hold?
NASDAQ : CTIC
CTI BioPharma Corp. — Analyst Ratings
$9.095 USD
$0.01 (0.06%)
- Volume
- 5.56M
- Average Volume
- 6.36M
- Market Capitalization
- $1.2B
- P/E Ratio
- -11.51
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $9.10
- Year Low
- $4.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.23
Analyst Consensus Summary
Consensus Rating
N/A
19 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
1.1%
vs Current Price
Price Target
$9.00
Average TargetPrice Target Range
Lowest Target
$9.00
1.1% UPSIDE
Average Target
$9.00
Median Estimate
Highest Target
$13.00
-30.0% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 19
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 13 | 6 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Jefferies | Kelly Shi | $13 | $6.28 | 2022-09-01 01:05 AM | 107.0% |
| DNB Markets | Leah Rush Cann | $12 | $4.73 | 2022-04-19 11:44 AM | 153.7% |
| BTIG | Robert Hazlett | $9 | $3.95 | 2022-03-02 07:00 PM | 127.8% |